(Q83863771)
Statements
A randomised phase II trial of 1 month versus 1 year of adjuvant high-dose interferon α-2b in high-risk acral melanoma patients (English)
Lili Mao
Lu Si
Zhihong Chi
Chuanliang Cui
Xinan Sheng
Siming Li
Bixia Tang